Studies, including ours, have demonstrated that PAFR activation enhances the in vitro proliferation and in vivo tumor growth of NSCLC cell lines via mechanisms involving the signal transducer and activator of transcription 3 (STAT3) signaling [18,29]. The gene discussed is STAT3; the disease is non-small cell lung carcinoma.